0001127602-23-030485.txt : 20231227 0001127602-23-030485.hdr.sgml : 20231227 20231227161138 ACCESSION NUMBER: 0001127602-23-030485 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231227 FILED AS OF DATE: 20231227 DATE AS OF CHANGE: 20231227 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WIERENGA WENDALL CENTRAL INDEX KEY: 0001235945 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50633 FILM NUMBER: 231518060 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL STREET 2: C/O NEUROCRINE BIOSCIENCES CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER NAME: FORMER CONFORMED NAME: WIERENGA WENDALL D DATE OF NAME CHANGE: 20030527 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTOKINETICS INC CENTRAL INDEX KEY: 0001061983 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943291317 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 350 OYSTER POINT BOULEVARD STREET 2: . CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 624-3000 MAIL ADDRESS: STREET 1: 350 OYSTER POINT BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2023-12-27 0001061983 CYTOKINETICS INC CYTK 0001235945 WIERENGA WENDALL 350 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 1 1 Common Stock 2023-12-27 4 M 0 5000 4.44 A 23653 D Common Stock 2023-12-27 4 S 0 5000 73.60 D 18653 D Common Stock 2023-12-27 4 M 0 5000 4.44 A 23653 D Common Stock 2023-12-27 4 S 0 5000 73.60 D 18653 D Non-Qualified Stock Option (Right to Buy) 4.44 2023-12-27 4 M 0 5000 0 D 2014-06-21 2024-05-21 Common Stock 5000 5000 D Non-Qualified Stock Option (Right to Buy) 4.44 2023-12-27 4 M 0 5000 0 D 2014-06-21 2024-05-21 Common Stock 5000 0 D Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on September 7, 2023. This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015. /s/ John Faurescu, attorney-in-fact for Dr. Wierenga 2023-12-27